Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Idexx Laboratories Inc. buy Morgan Stanley

Start price
€448.40
23.03.23 / 50%
Target price
€541.80
23.03.24
Performance (%)
9.77%
End price
€492.20
24.03.24
Summary
This prediction ended on 24.03.24 with a price of €492.20. The BUY prediction by Morgan_Stanley finished with a performance of 9.77%. Morgan_Stanley has a follow-up prediction for Idexx Laboratories Inc. where he still thinks Idexx Laboratories Inc. is a Buy. Morgan_Stanley has 50% into this prediction

IDEXX Laboratories, Inc. (Symbol: IDXX) is a leading global developer, manufacturer, and distributor of veterinary diagnostic and information technology products and services, primarily catering to companion animal healthcare, livestock and poultry, water testing, and dairy. The company operates through various segments including Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy, and Other Veterinary Businesses. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX Labs continues to innovate and grow, driven by a strong commitment to scientific innovation, customer service, and overall animal health and well-being. With a wide range of diagnostic products, software solutions, and connected services, IDXX plays a significant role in the veterinary care industry and serves customers across more than 175 countries.

Performance without dividends (%)
Name 1w 1m 1y
Idexx Laboratories Inc. 4.384% 4.384% 6.992%
iShares Core DAX® 2.594% -1.158% 14.782%
iShares Nasdaq 100 3.553% -1.727% 43.265%
iShares Nikkei 225® 0.687% -8.354% 18.454%
iShares S&P 500 2.209% -0.942% 31.361%

Comments by Morgan_Stanley for this prediction

In the thread Idexx Laboratories Inc. diskutieren
Prediction Buy
Perf. (%) 9.77%
Target price 541.797
Change
Ends at 23.03.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $543.00 to $590.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat

In the thread Trading Idexx Laboratories Inc.
Prediction Buy
Perf. (%) 9.77%
Target price 541.797
Change
Ends at 23.03.24

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Current prediction by Morgan_Stanley for Idexx Laboratories Inc.

buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€465.80
03.08.23
€547.68
03.08.24
0.19%
26.04.24